APGPR Enterostatin

Metabolite details

Identifier

ITZMJCSORYKOSI-AJNGGQMLSA-N

InChI Key

ITZMJCSORYKOSI-AJNGGQMLSA-N

IUPAC name

Preferred name

APGPR Enterostatin

INN name

—

Synonym

(2S)-2-{[(2S)-1-(2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}acetyl)pyrrolidin-2-yl]formamido}-5-[(diaminomethylidene)amino]pentanoic acid

ChEBI

CHEBI:89430

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Stage-specific roles of microbial dysbiosis and metabolic disorders in rheumatoid arthritis
• Transcriptomics and metabolomics analysis reveal the anti-oxidation and immune boosting effects of mulberry leaves in growing mutton sheep
• L-leucine increases the sensitivity of drug-resistant Salmonella to sarafloxacin by stimulating central carbon metabolism and increasing intracellular reactive oxygen species level (LC-MS positive mode)

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• Control_vs_nsPEF_7_day
• Healthy_vs_RAS4
• Control_vs_Fermented_Mulberry_Leaves
• SAR-S_vs_SAR-R